首页> 外文OA文献 >MP22-11 NADIR TESTOSTERONE 20 NG/DL PREDICT TESTOSTERONE RECOVERY TO SUPRACASTRATE LEVEL IN PROSTATE CANCER PATIENTS WHO RECEIVED EXTERNAL BEAM RADIOTHERAPY

【2h】

MP22-11 NADIR TESTOSTERONE 20 NG/DL PREDICT TESTOSTERONE RECOVERY TO SUPRACASTRATE LEVEL IN PROSTATE CANCER PATIENTS WHO RECEIVED EXTERNAL BEAM RADIOTHERAPY

机译：MP22-11 Nadir睾酮20 Ng / DL预测接受外部光束放射治疗的前列腺癌患者的睾酮恢复到前列腺癌患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Akinori Takei; Shinichi Sakamoto; Takaaki Tamura; Ken Wakai; Yusuke Imamura; Hitoshi Yano; Koji Kawamura; Takashi Imamoto; Akira Komiya; Koichiro Akakura; Tomohiko Ichikawa;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical Effect of Switching from a Luteinizing Hormone-Releasing Hormone Agonist to an Antagonist in Patients with Castration-Resistant Prostate Cancer and Serum Testosterone Level ≥ 20 ng/dl [J] . Soga N., Kageyama T., Ogura Y., Current urology. . 2015,第1期

机译：去势抵抗性前列腺癌且血清睾丸激素水平≥20 ng / dl的患者从黄体激素释放激素激动剂转换为拮抗剂的临床效果
2. Clinical Effect of Switching from a Luteinizing Hormone-Releasing Hormone Agonist to an Antagonist in Patients with Castration-Resistant Prostate Cancer and Serum Testosterone Level ≥20 ng/dl [J] . Norihito Soga, Takumi Kageyama, Yuji Ogura, Current urology. . 2015,第1期

机译：从旋转激素释放激素激动剂切换到抗阉割前列腺癌患者拮抗剂的临床疗效，血清睾酮水平≥20ng/ dl
3. Extended release, 6-month formulations of leuprolide acetate for the treatment of advanced prostate cancer: achieving testosterone levels below 20 ng/dl [J] . Crawford E. David, Moul Judd W., Sartor Oliver, Expert opinion on drug metabolism & toxicology . 2015,第9期

机译：醋酸亮丙瑞林的6个月缓释制剂用于治疗晚期前列腺癌：睾丸激素水平低于20 ng / dl
4. Pretreatment Serum Testosterone Level Can Predict Pathological Stage in Localized Prostate Cancer Patients Treated with Radical Prostatectomy [C] . T. Imamoto, H. Suzuki, S. Fukasawa, International Congress of Andrology . 2005

机译：预处理血清睾酮水平可以预测局部前列腺癌患者的病理阶段，其患有自由基前列腺切除术治疗
5. Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy [D] . TAKEI, Akinori 2019

机译：雄激素剥夺治疗的持续时间和最低20 ng / dL的睾丸激素最低值可预测接受外照射的前列腺癌患者的睾丸激素恢复至超水平
6. Clinical Effect of Switching from a Luteinizing Hormone-Releasing Hormone Agonist to an Antagonist in Patients with Castration-Resistant Prostate Cancer and Serum Testosterone Level ≥ 20 ng/dl [O] . Norihito Soga, Takumi Kageyama, Yuji Ogura, 2016

机译：抗去势抵抗前列腺癌和血清睾丸激素水平≥20 ng / dl的患者从黄体激素释放激素激动剂转换为拮抗剂的临床效果
7. Serum testosterone level after intensity-modulated radiotherapy in low-risk prostate cancer patients: does testicular dose correlate with testosterone level? [O] . Hiromichi Ishiyama, Bin S. Teh, Arnold C. Paulino, 2012

机译：血清睾酮水平在低风险前列腺癌患者中强度调节放疗后：睾丸剂量与睾酮水平相关吗？

MP22-11 NADIR TESTOSTERONE 20 NG/DL PREDICT TESTOSTERONE RECOVERY TO SUPRACASTRATE LEVEL IN PROSTATE CANCER PATIENTS WHO RECEIVED EXTERNAL BEAM RADIOTHERAPY

著录项

引文网络

相似文献

相关主题

期刊订阅